Apatinib Mesylate Tablets of joint mFOLFOX6 neoadjuant chemotherapy in locally advanced colorectal cancer clinical research

ABSTRACT: Interventions: Case series:Apatinib Mesylate Tablets of joint mFOLFOX6 neoadjuant chemotherapy Primary outcome(s): pathologic complete response;Objective response rate;Drop period to ensure operation resection Study Design: Case series

DISEASE(S): Colorectal Cancer

PROVIDER: 2670768 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR